Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome

Fertility and Sterility

Volumn 87, Issue 2, 2007, Pages 321-328

  Maliqueo, Manuel ^a   Bacallao, Ketty ^a   Quezada, Susana ^a   Clementi, Marisa ^a   Gabler, Fernando ^b   Johnson, M Cecilia ^a   Vega, Margarita ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

endometrium; polycystic ovary syndrome; Sex hormone binding globulin

Indexed keywords

ESTRADIOL; INSULIN; MESSENGER RNA; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CELL; EPITHELIUM CELL; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOLOGICAL MARKERS; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MENSTRUAL CYCLE; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN;

EID: 33846622901     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.06.038     Document Type: Article

References (46)

1. Adams J., Polson D.W., and Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J [Clin Res] 293 (1986) 355-359
2. Hull M.G. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1 (1987) 235-245
3. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J., Haseltine F., and Merrian G. (Eds). Current issues in endocrinology and metabolism: polycystic ovary syndrome (1992), Blackwell, New York 377-384
4. Ehrmann D.A., Barnes R.B., and Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16 (1995) 322-353
5. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
6. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
7. Dunaif A., Graf M., Mandeli J., Laumas V., and Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65 (1987) 499-507
8. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
9. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 10 (1996) 221-247
10. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774-800
11. Acien P., Quereda F., Matallin P., Villarroya E., Lopez-Fernandez J.A., Acien M., et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 72 (1999) 32-40
12. Ovalle F., and Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 77 (2002) 1095-1105
13. Coulam C.B., Annegers J.F., and Kranz J.S. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 61 (1983) 403-407
14. Dahlgren E., Johansson S., Lindstedt G., Knutsson F., Oden A., Janson P.O., et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57 (1992) 505-513
15. Segreti E.M. Endometrial hyperplasia and carcinoma in women with androgen excess disorders. In: Azziz R., Nestler J., and Dewailly D. (Eds). Androgen excess disorders in women (1997), Lippincott-Raven, Philadelphia 667-672
16. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 7 (2001) 522-525
17. Hardiman P., Pillay O.C., and Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 361 (2003) 1810-1812
18. Pardridge W.M. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 15 (1986) 259-278
19. Toscano V., Balducci R., Bianchi P., Guglielmi R., Mangiantini A., and Sciarra F. Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem Mol Biol 43 (1992) 431-437
20. Haffner S.M. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm Res 45 (1996) 233-237
21. Strel'chyonok O.A., Avvakumov G.V., and Survilo L.I. A recognition system for sex-hormone-binding protein-estradiol complex in human decidual endometrium plasma membranes. Biochim Biophys Acta 802 (1984) 459-466
22. Rosner W., Hryb D.J., Khan M.S., Nakhla A.M., and Romas N.A. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol 69 (1999) 481-485
23. Carlstrom K., Gershagen S., and Rannevik G. Free testosterone and testosterone/SHBG index in hirsute women: a comparison of diagnostic accuracy. Gynecol Obstet Invest 24 (1987) 256-261
24. Nestler J.E., Powers L.P., Matt D.W., Steingold K.A., Plymate S.R., Rittmaster R.S., et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72 (1991) 83-89
25. Buyalos R.P., Geffner M.E., Watanabe R.M., Bergman R.N., Gornbein J.A., and Judd H.L. The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertil Steril 60 (1993) 626-633
26. Misao R., Fujimoto J., Itoh N., Nakanishi Y., and Tamaya T. Localization of sex hormone-binding globulin mRNA expression in human uterine endometrium. Gynecol Endocrinol 11 (1997) 1-4
27. Noé G. Sex hormone binding globulin expression and colocalization with estrogen receptor in the human fallopian tube. J Steroid Biochem Mol Biol 68 (1999) 111-117
28. Misao R., Nakanishi Y., Fujimoto J., Hori M., Ichigo S., and Tamaya T. Expression of sex hormone-binding globulin mRNA in human ovarian cancers. Eur J Endocrinol 133 (1995) 327-334
29. Hammond G.L., Underhill D.A., Rykse H.M., and Smith C.L. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Mol Endocrinol 3 (1989) 1869-1876
30. Misao R., Fujimoto J., Nakanishi Y., and Tamaya T. Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human uterine endometrium. J Steroid Biochem Mol Biol 62 (1997) 385-390
31. Misao R., Nakanishi Y., Fujimoto J., Iwagaki S., and Tamaya T. Dominant expression of sex-hormone-binding-globulin exon-7 splicing variant over wild-type mRNA in human ovarian cancers. Int J Cancer 77 (1998) 828-832
32. Misao R., Iwagaki S., Fujimoto J., Nakanishi Y., Sun W.S., and Tamaya T. Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers. J Steroid Biochem Mol Biol 68 (1999) 103-109
33. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
34. Guermandi E., Vegetti W., Bianchi M.M., Uglietti A., Ragni G., and Crosignani P. Reliability of ovulation tests in infertile women. Obstet Gynecol 97 (2001) 92-96
35. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
36. American Diabetes Association. Report of expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 Suppl 1 (1997) 1183-1197
37. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Fertil Steril 1 (1950) 3-25
38. Kurman R.J., Kaminski P.F., and Norris H.J. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
39. Lessey B.A., Killam A.P., Metzger D.A., Haney A.F., Greene G.L., and McCarty K.S. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67 (1988) 333-339
40. Castro A., Johnson M.C., Anido M., Cortinez A., Gabler F., and Vega M. Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil Steril 78 (2002) 587-595
41. Maliqueo M., Clementi M., Gabler F., Johnson M.C., Palomino A., Sir-Petermann T., et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 80 Suppl 2 (2003) 812-819
42. Tsai S.J., Wu M.H., Chen H.M., Chuang P.C., and Wing L.Y. Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology 143 (2002) 2715-2721
43. Pierro E., Minici F., Alesiani O., Miceli F., Proto C., Screpanti I., et al. Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium. Biol Reprod 64 (2001) 831-838
44. Lecce G., Meduri G., Ancelin M., Bergeron C., and Perrot-Applanat M. Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 86 (2001) 1379-1386
45. Villavicencio A., Bacallao K., Avellaira C., Gabler F., Fuentes A., and Vega M. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol Oncol 103 (2006) 307-314
46. Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril 85 (2006) 1319-1340